Sign up to save your podcasts
Or
Share Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Inside the Lemonaid Health Buy: Kyle Pretsch on Bambu Ventures’s Bold Play
Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.
View all episodes
By Bambu Ventures's Kyle Pretsch dives into Lemonaid’s $10M buyout, down from 23andMe’s $400M price tag, and what’s next after Chrome Co.’s dramatic pivot.